Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers

Sickle-cell disease

Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504 · see citing works

Global Burden of Sickle Cell Anaemia in Children under Five, 2010–2050: Modelling Based on Demographics, Excess Mortality, and Interventions

Piel, F. B., Hay, S. I., Gupta, S., Weatherall, D. J., & Williams, T. N. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001484 · Cited by 1,144 · see citing works

HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry

Gragert, L. A., Eapen, M., Williams, E., Freeman, J., Spellman, S. R., Baitty, R. L., Hartzman, R. J., Rizzo, J. D., Horowitz, M. M., Confer, D. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmsa1311707 · Cited by 1,114 · see citing works

Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor

Deng, W., Lee, J., Wang, H., Miller, J., Reik, A., Gregory, P. D., Dean, A., & Blobel, G. A. (2012) · Cell · doi:10.1016/j.cell.2012.03.051 · Cited by 734 · see citing works

Reactivation of developmentally silenced globin genes by forced chromatin looping

Deng, W., Rupon, J. W., Krivega, I., Breda, L., Motta, I., Jahn, K. S., Reik, A., Gregory, P. D., Rivella, S., Dean, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.050 · Cited by 443 · see citing works

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

Voskaridou, E., Christoulas, D., Bilalis, A., Plata, E., Varvagiannis, K., Stamatopoulos, G., Sinopoulou, K., Balassopoulou, A., Loukopoulos, D., & Terpos, E. (2010) · Blood · doi:10.1182/blood-2009-05-221333 · Cited by 430 · see citing works

KLF1 regulates BCL11A expression and γ- to β-globin gene switching

Zhou, D., Liu, K., Sun, C.-W., Pawlik, K. M., & Townes, T. M. (2010) · Nature Genetics · doi:10.1038/ng.637 · Cited by 367 · see citing works

Hydroxyurea for the Treatment of Sickle Cell Anemia

Platt, O. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0708272 · Cited by 357 · see citing works

Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing

Xu, J., Peng, C., Sankaran, V. G., Shao, Z., Esrick, E. B., Chong, B. G., Ippolito, G. C., Fujiwara, Y., Ebert, B. L., Tucker, P. W., et al. (2011) · Science · doi:10.1126/science.1211053 · Cited by 326 · see citing works

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease

Zimmerman, S. A., Schultz, W. H., Davis, J. S., Pickens, C. V., Mortier, N. A., Howard, T. A., & Ware, R. E. (2003) · Blood · doi:10.1182/blood-2003-07-2475 · Cited by 312 · see citing works

Hydroxyurea in the treatment of sickle-cell anemia.

Lw, H., & Kennedy, L. D. (1997) · PubMed · Cited by 250 · see citing works

Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease

Noguchi, C. T., Rodgers, G. P., Serjeant, G., & Schechter, A. N. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801143180207 · Cited by 222 · see citing works

A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.

Rivella, S., May, C., Chadburn, A., Rivière, I., & Sadelain, M. (2003) · Blood · doi:10.1182/blood-2002-10-3305 · Cited by 220 · see citing works

Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells

Parseval, L. M., Verhelle, D., Glezer, E., Jensen-Pergakes, K., Ferguson, G. D., Corral, L. G., Morris, C. L., Muller, G. W., Brady, H. A., & Chan, K. W. H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32322 · Cited by 182 · see citing works

Successful correction of the human β-thalassemia major phenotype using a lentiviral vector

Puthenveetil, G., Scholes, J., Carbonell, D. J., Qureshi, N., Xia, P., Zeng, L., Li, S., Yu, Y., Hiti, A. L., Yee, J., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1427 · Cited by 182 · see citing works

Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction

Shi, L., Cui, S., Engel, J. D., & Tanabe, O. (2013) · Nature Medicine · doi:10.1038/nm.3101 · Cited by 172 · see citing works

The degree of phenotypic correction of murine β-thalassemia intermedia following lentiviral-mediated transfer of a human γ-globin gene is influenced by chromosomal position effects and vector copy number

Persons, D. A., Hargrove, P. W., Allay, E. R., Hanawa, H., & Nienhuis, A. W. (2003) · Blood · doi:10.1182/blood-2002-07-2211 · Cited by 155 · see citing works

miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction

Guda, S., Brendel, C., Renella, R., Du, P., Bauer, D. E., Canver, M. C., Grenier, J. K., Grimson, A., Kamran, S. C., Thornton, J. E., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.113 · Cited by 120 · see citing works

Extended β-globin locus control region elements promote consistent therapeutic expression of a γ-globin lentiviral vector in murine β-thalassemia

Hanawa, H., Hargrove, P. W., Kepes, S., Srivastava, D. K., Nienhuis, A. W., & Persons, D. A. (2004) · Blood · doi:10.1182/blood-2004-03-0863 · Cited by 114 · see citing works

Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer

Wilber, A. C., Hargrove, P. W., Kim, Y., Riberdy, J. M., Sankaran, V. G., Papanikolaou, E., Georgomanoli, M., Anagnou, N. P., Orkin, S. H., Nienhuis, A. W., et al. (2010) · Blood · doi:10.1182/blood-2010-08-300723 · Cited by 98 · see citing works

Thalassemia: An Overview of 50 Years of Clinical Research

Sankaran, V. G., & Nathan, D. G. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.009 · Cited by 67 · see citing works

Update of hematopoietic cell transplantation for sickle cell disease

Walters, M. C. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000136 · Cited by 43 · see citing works

Genetic Therapy for Beta-Thalassemia: From the Bench to the Bedside

Arumugam, P. I., & Malik, P. (2010) · Hematology · doi:10.1182/asheducation-2010.1.445 · Cited by 40 · see citing works

Outcomes of Gene Therapy for Severe Sickle Disease and Beta-Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex Vivo with a Lentiviral Beta AT87Q-Globin Vector

Cavazzana, M., Ribeil, J., Payen, E., Suárez, F., Beuzard, Y., Touzot, F., Cavallesco, R., Lefrère, F., Chrétien, S., Bourget, P., et al. (2015) · Blood · doi:10.1182/blood.v126.23.202.202 · Cited by 36 · see citing works

Update of Results from the Northstar Study (HGB-204): A Phase 1/2 Study of Gene Therapy for Beta-Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex-Vivo with a Lentiviral Beta AT87Q-Globin Vector (LentiGlobin BB305 Drug Product)

Walters, M. C., Rasko, J. E. J., Hongeng, S., Kwiatkowski, J. L., Schiller, G. J., Kletzel, M., Ho, P. J., Vichinsky, E. P., Kalle, C. V., Cavazzana, M., et al. (2015) · Blood · doi:10.1182/blood.v126.23.201.201 · Cited by 31 · see citing works

In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in β-thalassemia/hemoglobin E patients

Watanapokasin, Y., Chuncharunee, S., Sanmund, D., Kongnium, W., Winichagoon, P., Rodgers, G. P., & Fucharoen, S. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.09.006 · Cited by 28 · see citing works

Sickle-cell disease

Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504 · see citing works

Sickle cell disease

Ware, R. E., de Montalembert, M., Tshilolo, L. M., & Abboud, M. R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30193-9 · Cited by 1,004 · see citing works

In vivo hematopoietic stem cell modification by mRNA delivery

Breda, L., Papp, T. E., Triebwasser, M. P., Yadegari, A., Fedorky, M. T., Tanaka, N., Abdulmalik, O. Y., Pavani, G., Wang, Y., Grupp, S. A., et al. (2023) · Science · doi:10.1126/science.ade6967 · Cited by 338 · see citing works

Molecular basis of β thalassemia and potential therapeutic targets

Thein, S. L. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.06.001 · Cited by 208 · see citing works

Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus

Antoniani, C., Meneghini, V., Lattanzi, A., Felix, T., Romano, O., Magrin, E., Weber, L., Pavani, G., El Hoss, S., Kurita, R., et al. (2018) · Blood · doi:10.1182/blood-2017-10-811505 · Cited by 194 · see citing works

Recent Advances in the Treatment of Sickle Cell Disease

Cisneros, G. S., & Thein, S. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00435 · Cited by 204 · see citing works

Sickle Cell Anemia and Its Phenotypes

Williams, T. N., & Thein, S. L. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021320 · Cited by 151 · see citing works

Fetal hemoglobin in sickle cell anemia

Steinberg, M. H. (2020) · Blood · doi:10.1182/blood.2020007645 · Cited by 136 · see citing works

Gene Therapy for β-Hemoglobinopathies

Cavazzana, M., Antoniani, C., & Miccio, A. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.024 · Cited by 128 · see citing works

Gene therapy for sickle cell disease: An update

Demirci, S., Uchida, N., & Tisdale, J. F. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.04.003 · Cited by 119 · see citing works

Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major

Psatha, N., Reik, A., Phelps, S. R., Zhou, Y., Dalas, D., Yannaki, E., Levasseur, D. N., Urnov, F. D., Holmes, M. C., & Papayannopoulou, T. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.08.003 · Cited by 115 · see citing works

Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies

Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114 · see citing works

Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies

Magrin, E., Miccio, A., & Cavazzana, M. (2019) · Blood · doi:10.1182/blood.2019000949 · Cited by 97 · see citing works

Pathophysiology and treatment of patients with beta-thalassemia – an update

Fibach, E., & Rachmilewitz, E. A. (2017) · F1000Research · doi:10.12688/f1000research.12688.1 · Cited by 91 · see citing works

Oxidative Stress in β-Thalassemia

Fibach, E., & Dana, M. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0373-5 · Cited by 89 · see citing works

Fetal haemoglobin induction in sickle cell disease

Paikari, A., & Sheehan, V. (2017) · British Journal of Haematology · doi:10.1111/bjh.15021 · Cited by 87 · see citing works

Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery

Leonard, A. K., Bonifacino, A. C., Dominical, V. M., Luo, M., Haro‐Mora, J. J., Demirci, S., Uchida, N., Pierciey, F. J., & Tisdale, J. F. (2019) · British Journal of Haematology · doi:10.1111/bjh.15902 · Cited by 76 · see citing works

Modulating gene regulation to treat genetic disorders

Matharu, N. K., & Ahituv, N. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0083-7 · Cited by 75 · see citing works

Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of β-thalassemia

Guerra, A., Oikonomidou, P. R., Sinha, S., Zhang, J., Presti, V. L., Hamilton, C. R., Breda, L., Casu, C., La, P., Martins, A. C., et al. (2019) · Blood · doi:10.1182/blood.2019001057 · Cited by 65 · see citing works

Gene Therapy for Hemoglobinopathies

Cavazzana, M., & Mavilio, F. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.122 · Cited by 60 · see citing works

Engineering 3D genome organization

Wang, H., Han, M., & Qi, L. S. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00325-5 · Cited by 58 · see citing works

New therapeutic targets in transfusion-dependent and -independent thalassemia

Cappellini, M. D., & Motta, I. (2017) · Hematology · doi:10.1182/asheducation-2017.1.278 · Cited by 57 · see citing works

Gene Therapy Approaches to Hemoglobinopathies

Ferrari, G., Cavazzana, M., & Mavilio, F. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.06.010 · Cited by 56 · see citing works

Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective

Bou‐Fakhredin, R., Franceschi, L. D., Motta, I., Cappellini, M. D., & Taher, A. T. (2022) · Pharmaceuticals · doi:10.3390/ph15060753 · Cited by 55 · see citing works

YY1-controlled regulatory connectivity and transcription are influenced by the cell cycle

Lam, J. C., Aboreden, N. G., Midla, S. C., Wang, S., Huang, A., Keller, C. A., Giardine, B. M., Henderson, K. A., Hardison, R. C., Zhang, H., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01871-y · Cited by 45 · see citing works

SIRT1 activates the expression of fetal hemoglobin genes

Dai, Y., Chen, T., Ijaz, H., Cho, E. H., & Steinberg, M. H. (2017) · American Journal of Hematology · doi:10.1002/ajh.24879 · Cited by 46 · see citing works

Sickle cell disease: progress towards combination drug therapy

Pace, B. S., Starlard‐Davenport, A., & Kutlar, A. (2021) · British Journal of Haematology · doi:10.1111/bjh.17312 · Cited by 43 · see citing works

Hematopoietic Stem Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies

Drysdale, C. M., Nassehi, T., Gamer, J., Yapundich, M., Tisdale, J. F., & Uchida, N. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.01.001 · Cited by 39 · see citing works

Pharmacological and molecular approaches for the treatment of β‐hemoglobin disorders

Lohani, N., Bhargava, N., Munshi, A., & Ramalingam, S. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26292 · Cited by 38 · see citing works

Genetic therapies for sickle cell disease

Esrick, E. B., & Bauer, D. E. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.014 · Cited by 37 · see citing works

Gene Therapy of the Hemoglobinopathies

Kunz, J. B., & Kulozik, A. E. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000479 · Cited by 38 · see citing works

Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges

Ghiaccio, V., Chappell, M., Rivella, S., & Breda, L. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00383-4 · Cited by 29 · see citing works

Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option

Starlard‐Davenport, A., Gu, Q., & Pace, B. S. (2022) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-022-00589-z · Cited by 27 · see citing works

Investigational drugs in phase I and phase II clinical trials for thalassemia

Motta, I., Scaramellini, N., & Cappellini, M. D. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1335709 · Cited by 24 · see citing works

Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System

Mussolino, C., Alzubi, J., Pennucci, V., Turchiano, G., & Cathomen, T. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.149 · Cited by 23 · see citing works

Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies

Breda, L., Ghiaccio, V., Tanaka, N., Jarocha, D. J., Ikawa, Y., Abdulmalik, O. Y., Dong, A., Casu, C., Raabe, T. D., Shan, X., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.036 · Cited by 23 · see citing works

Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies

Loucari, C. C., Patsali, P., van Dijk, T. B., Stephanou, C., Papasavva, P. L., Zanti, M., Kurita, R., Nakamura, Y., Christou, S., Sitarou, M., et al. (2018) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.190 · Cited by 23 · see citing works

Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies

Venkatesan, V., Srinivasan, S., Babu, P., & Thangavel, S. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-20 · Cited by 22 · see citing works

3′HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression

Himadewi, P., Wang, X. Q. D., Feng, F., Gore, H., Liu, Y.-S., Yu, L., Kurita, R., Nakamura, Y., Pfeifer, G., Liu, J., et al. (2021) · bioRxiv · doi:10.7554/elife.70557 · Cited by 16 · see citing works

A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies

Zittersteijn, H. A., Harteveld, C. L., Klaver-Flores, S., Lankester, A. C., Hoeben, R. C., Staal, F. J. T., & Gonçalves, M. A. F. V. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.617780 · Cited by 20 · see citing works

Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies

Brusson, M., Chalumeau, A., Martinucci, P., Romano, O., Félix, T., Poletti, V., Scaramuzza, S., Ramadier, S., Masson, C., Ferrari, G., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.03.012 · Cited by 23 · see citing works

PUM1 mediates the posttranscriptional regulation of human fetal hemoglobin

Elagooz, R., Dhara, A. R., Gott, R. M., Adams, S. E., White, R. A., Ghosh, A., Ganguly, S., Man, Y., Owusu-Ansah, A. T., Mian, O. Y., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006730 · Cited by 18 · see citing works

Genetic and Epigenetic Mechanisms of β-Globin Gene Switching

Iarovaia, O. V., Kovina, A. P., Petrova, N. V., Razin, S. V., Ioudinkova, E. S., Vassetzky, Y. S., & Ulianov, S. V. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918040090 · Cited by 18 · see citing works

Sustained fetal hemoglobin induction in vivo is achieved by BCL11A interference and coexpressed truncated erythropoietin receptor

Uchida, N., Ferrara, F., Drysdale, C. M., Yapundich, M., Gamer, J., Nassehi, T., DiNicola, J., Shibata, Y., Wielgosz, M. M., Kim, Y., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb0411 · Cited by 16 · see citing works

Serum-free Erythroid Differentiation for Efficient Genetic Modification and High-Level Adult Hemoglobin Production

Uchida, N., Demirci, S., Haro‐Mora, J. J., Fujita, A., Raines, L. N., Hsieh, M. M., & Tisdale, J. F. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.03.007 · Cited by 16 · see citing works

Enhancer Function in the 3D Genome

Razin, S. V., Ulianov, S. V., & Iarovaia, O. V. (2023) · Genes · doi:10.3390/genes14061277 · Cited by 15 · see citing works

Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.

Bauer, D. E., Brendel, C., & Fitzhugh, C. (2017) · Blood Cells, Molecules & Diseases · doi:10.1016/j.bcmd.2017.08.014 · Cited by 14 · see citing works

The intrinsic genetic and epigenetic regulator factors as therapeutic targets, and the effect on fetal globin gene expression

Adelvand, P., Hamid, M., & Sardari, S. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2018.1406795 · Cited by 13 · see citing works

The two waves in single-cell 3D genomics

Ulianov, S. V., & Razin, S. V. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.021 · Cited by 14 · see citing works

Clinical Manifestations of Sickle Cell Disease Across the Lifespan

Pecker, L. H., & Little, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-62328-3_1 · Cited by 13 · see citing works

Targeting HIF-1α in sickle cell disease and cancer: unraveling therapeutic opportunities and risks

Ubaid, S., Kashif, M., Laiq, Y., Nayak, A., Kumar, V., & Singh, V. K. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2367640 · Cited by 11 · see citing works

NRF2 mediates γ-globin gene regulation through epigenetic modifications in a β-YAC transgenic mouse model

Zhu, X., Xi, C., Ward, A., Takezaki, M., Shi, H., Peterson, K. R., & Pace, B. S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220945305 · Cited by 11 · see citing works

Molecular Determinants of Lung Morphogenesis

Swarr, D. T., Wert, S. E., & Whitsett, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44887-1.00002-x · Cited by 10 · see citing works

Enhancers and their dynamics during hematopoietic differentiation and emerging strategies for therapeutic action

Cico, A., Andrieu‐Soler, C., & Soler, É. (2016) · FEBS Letters · doi:10.1002/1873-3468.12424 · Cited by 9 · see citing works

Forced enhancer-promoter rewiring to alter gene expression in animal models

Peslak, S. A., Demirci, S., Chandra, V., Ryu, B. Y., Bhardwaj, S. K., Jiang, J., Rupon, J. W., Throm, R. E., Uchida, N., Leonard, A. K., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.01.016 · Cited by 7 · see citing works

Robust erythroid differentiation system for rhesus hematopoietic progenitor cells allowing preclinical screening of genetic treatment strategies for the hemoglobinopathies

Demirci, S., Bhardwaj, S. K., Uchida, N., Haro‐Mora, J. J., Ryu, B. Y., Blobel, G. A., & Tisdale, J. F. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.07.002 · Cited by 7 · see citing works

Cohesin mutations and chromatin changes in cancer

Swett, A. D., & Tóthová, Z. (2025) · International Journal of Cancer · doi:10.1002/ijc.35378 · Cited by 6 · see citing works

Identification of a genomic DNA sequence that quantitatively modulates KLF1 transcription factor expression in differentiating human hematopoietic cells

Gnanapragasam, M. N., Planutis, A., Glassberg, J., & Bieker, J. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-34805-5 · Cited by 6 · see citing works

Disentangling chromatin architecture to gain insights into the etiology of brain disorders

Lamonica, J. M., & Zhou, Z. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.06.009 · Cited by 6 · see citing works

Therapeutic advances in sickle cell disease in the last decade

Shet, A. S., & Thein, S. L. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1153_17 · Cited by 5 · see citing works

Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBBIVSI−110 (G > A) β-Thalassemia

Patsali, P., Papasavva, P. L., Christou, S., Sitarou, M., Antoniou, M. N., Lederer, C. W., & Kleanthous, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186671 · Cited by 5 · see citing works

Single-stranded DNA binding proteins are essential components of the architectural LDB1 protein complex

Wang, X., Aboreden, N. G., Cai, Y., Lam, J. C., Henderson, K. A., Xiang, J., Giardine, B. M., Hardison, R. C., Keller, C. A., Nagarajan, L., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.07.012 · Cited by 4 · see citing works

Gene-environmental influence of space and microgravity on red blood cells with sickle cell disease

Igbineweka, N. E., & van Loon, J. J. W. A. (2024) · npj Genomic Medicine · doi:10.1038/s41525-024-00427-7 · Cited by 4 · see citing works

High level of fetal-globin reactivation by designed transcriptional activator-like effector

Zhan, J., Irudayam, M. J., Nakamura, Y., Kurita, R., & Nienhuis, A. W. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000482 · Cited by 4 · see citing works

3D Genomics

Razin, S., Ulianov, S., & Gavrilov, A. (2019) · Molecular Biology · doi:10.1134/s0026893319060153 · Cited by 4 · see citing works

Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia

Gemmo, C., Breveglieri, G., Marzaro, G., Lampronti, I., Cosenza, L. C., Gasparello, J., Zuccato, C., Fabbri, E., Borgatti, M., Chilin, A., et al. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-01987-9 · Cited by 3 · see citing works

DNA regulatory element cooperation and competition in transcription

Lee, H., Friedman, M. J., Kim, S. B., & Oh, S. (2024) · BMB Reports · doi:10.5483/bmbrep.2024-0069 · Cited by 3 · see citing works

Pathobiology of Sickle Cell Disease Vaso-occlusion and Targeted Therapies

Morrone, K. A., Davila, J. G., Mitchell, W. B., & Manwani, D. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-62328-3_2 · Cited by 3 · see citing works

2'-O-methoxyethyl splice-switching oligos correct splicing from IVS2-745 β-thalassemia patient cells restoring HbA production and chain rebalance

Dong, A., Ghiaccio, V., Motta, I., Guo, S., Peralta, R. Q., Freier, S. M., Watt, A., Damle, S. S., Ikawa, Y., Jarocha, D. J., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.226852 · Cited by 2 · see citing works

Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategiesPreprint

Brusson, M., Chalumeau, A., Martinucci, P., Romano, O., Poletti, V., Scaramuzza, S., Ramadier, S., Masson, C., Ferrari, G., Mavilio, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.31.522279 · Cited by 2 · see citing works

scITDG: a tool for identifying time-dependent genes in single-cell transcriptome sequencing data

Zheng, Y., Liu, C., Zhang, W., Qu, J., Ma, S., & Liu, G. (2025) · Marine Life Science & Technology · doi:10.1007/s42995-025-00311-y · Cited by 1 · see citing works

Gentherapie von Hämoglobinkrankheiten – aktuelle Konzepte und Herausforderungen

Kulozik, A. E., & Kunz, J. B. (2019) · Transfusionsmedizin · doi:10.1055/a-0825-9666 · Cited by 1 · see citing works

Gene Therapy: Hemoglobinopathies

(2015) · The SAGE Encyclopedia of Stem Cell Research · doi:10.4135/9781483347660.n159

Prioritization of The Zinc finger domain within BCL11A by the Amelioration capability of hemoglobinopathies using CRISPR-Cas9 technologyPreprint

Mumtaz, K., Hussain, I., Iftikhar, F., Rehman, F. U., Jameel, M., Farooq, S., Hassan, H., Fatima, A., Ottmann, O. G., & Mian, A. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.28.568974

Applied Stem Cell Research in Sickle Cell Disease

Kiumarsi, A., Rostami, T., & Mohammadi, M. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00027-5

Genome and Epigenome Engineering Approaches to Studying Neuronal Activity-Dependent Transcriptional Enhancers

Narayanan, A., & West, A. E. (2024) · Springer eBooks · doi:10.1007/978-3-031-68550-7_7

Research progress of chromatin imaging and manipulation

Liu, M., Li, Q., Ma, Y., Tang, H., Huang, K., & Wang, H. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0105

The Role of Spatial Organization of the Genome in the Regulation of Transcription

Razin, S. V. (2025) · Russian Journal of Genetics · doi:10.1134/s1022795425700917

New therapeutic strategies for the treatment of β-hemoglobinopathies

Weber, L. (2018) · theses.fr (ABES) · doi:10.70675/09314463zdfd1z46b4z9c0cz32c6c2c5ccc2

Measurement and analysis of the protective effects of anti-sickling hemoglobins in sickle cell disease : application to gene therapy strategies

Hebert, N. (2020) · theses.fr (ABES) · doi:10.70675/7100e782ze144z4a6cz8bd0z88c8e98484f0

Base editing approaches for the treatment of β-hemoglobinopathies

Antoniou, P. (2021) · theses.fr (ABES) · doi:10.70675/c4dddb32zf8aez4bc3z8cf8zce9a4e808265

LDB1-dependent enhancer connectivity defines T-cell leukemia identities and masks metabolic vulnerabilitiesPreprint

Bhansali, R. S., Long, J. S., Pölönen, P., Isobe, T., Wang, S., Zhang, S., Geng, Z., Tausif, A., Antopia, M. C., Aboreden, N. G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.29.733236

Perspective Chapter: Fetal Hemoglobin Modulators

Walke, V. A. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1017037

Comparing Strategies to Reactivate Fetal Globin Expression for the Treatment of Beta-Globinopathies

Breda, L., Rupon, J. W., Motta, I., Deng, W., Blobel, G. A., & Rivella, S. (2014) · Blood · doi:10.1182/blood.v124.21.333.333 · Cited by 1 · see citing works

Using Forced Chromatin Looping To Overcome Developmental Silencing Of Embryonic and Fetal β-Type Globin Genes In Adult Erythroid Cells

Rupon, J. W., Deng, W., Wang, H., Gregory, P. D., Reik, A., Dean, A., & Blobel, G. A. (2013) · Blood · doi:10.1182/blood.v122.21.433.433 · Cited by 4 · see citing works

Controlling Long-Range Genomic Interactions to Reprogram the β-Globin Locus

Deng, W., Rupon, J. W., Wang, H., Reik, A., Gregory, P. D., & Blobel, G. A. (2012) · Blood · doi:10.1182/blood.v120.21.280.280

Mechanistic Insights into Forced Chromatin Looping Mediated Activation of Fetal Globin Gene Expression

Bartman, C., Blobel, G. A., Grevet, J. D., Hsiung, C. C. ‐., Rupon, J. W., & Raj, A. (2014) · Blood · doi:10.1182/blood.v124.21.331.331

LSD1 Inhibition Induces Fetal Hemoglobin Expression and Provides a Novel Therapeutic Approach to Sickle Cell Disease

Lee, S. H., Soloviev, M. V., Zhang, Y., Roman, V. D., Yang, G., Bowman, K., Burke, K., Margulis, A. R., O’Connor, S., Yang, Y., et al. (2016) · Blood · doi:10.1182/blood.v128.22.2472.2472